Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pangenomic Health Inc
C.NARA
Healthcare
Medical Devices
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:NARA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(241)
•••
Traderstock101
X
Post by
Traderstock101
on May 31, 2023 10:00am
Pangenomic signs LOI to license IHI's CyberPatient
2023-05-30 13:19 ET - News Release Ms. Maryam Marissen reports PANGENOMIC HEALTH SIGNS NON-BINDING LETTER OF INTENT FOR AN EXCLUSIVE SPECIAL PURPOSE LICENCE OF THE CYBERPATIENT AI MEDICAL
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 09, 2023 7:30am
New Press Release - PanGenomic Health's NARA Debuts New Website, Visual Identity & Natural Wellness E-Commerce Store
VANCOUVER, BC, Feb. 9, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that, further to the announcement made on January 9, 2023, the Company has launched its new visual identity, website and e-commerce store for its NARA brand...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 02, 2023 7:31am
New Press Release - PanGenomic Health Subsidiary Signs Rental Agreement with Psy Integrated Health, Makes Progress Towards Development of Joint Testing Facility
VANCOUVER, BC, Feb. 2, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. (formerly named PlantGx Diagnostics Corp.)("MUJN Diagnostics...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 31, 2023 7:31am
New Press Release - PanGenomic Health Announces Intention to Dual List on the UK Aquis Stock Exchange Growth Market
VANCOUVER, BC, Jan. 31, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission to trading on the Aquis Stock Exchange Growth Market ("AQSE") in the UK. Novum Securities Ltd. has been appointed as the...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 26, 2023 7:30am
New Press Release - PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture
VANCOUVER, BC, Jan. 26, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (formerly named PlantGx Diagnostics Corp.)("MUJN Diagnostics"), has signed a non-binding memorandum of understanding ("MoU")...
read article.
(25)
•••
Pennyscalper99
X
Post by
Pennyscalper99
on Jan 23, 2023 7:52pm
Discord link for nara.
https://discord.gg/9tGYDY8Uhr
(25)
•••
1991nightmaress
X
Comment by
1991nightmaress
on Jan 23, 2023 8:47am
RE:RE:RE:RE:RE:RE:Sell on News?
More headhunters for a cheap entry or a bit of recovery this week ????????
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 23, 2023 7:30am
New Press Release - PanGenomic Health's Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs
VANCOUVER, BC, Jan. 23, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science-backed information about natural remedy alternatives to...
read article.
(25)
•••
Pennyscalper99
X
Comment by
Pennyscalper99
on Jan 22, 2023 5:05pm
RE:RE:RE:RE:RE:Sell on News?
FOMO happened now few houses are selling to buy back cheap. Lower their average.
(25)
•••
1991nightmaress
X
Comment by
1991nightmaress
on Jan 22, 2023 2:45pm
RE:RE:RE:RE:Sell on News?
So far all I'm hearing here is a couple of folks looking for cheap shares or to cover a short ???????????
(25)
•••
1991nightmaress
X
Comment by
1991nightmaress
on Jan 22, 2023 2:44pm
RE:RE:RE:Sell on News?
https://www.investmentexecutive.com/newspaper_/news-newspaper/anonymous-comments-prove-costly/
(263)
•••
kegman
X
Comment by
kegman
on Jan 22, 2023 9:50am
RE:RE:Sell on News?
Looking. This could be the new base for the placement. I heard they were going to be ramping up the business in 2023 but did not expect the volume we saw. I am sure there were some
...more
(11)
•••
Boilerroomben
X
Post by
Boilerroomben
on Jan 21, 2023 12:51am
Any recommendations for another ?
High volume pump and dump?
(0)
•••
reefready
X
Post by
reefready
on Jan 21, 2023 12:34am
smell
That didn`t smell a bit? No volume, write up,mega volume, bottom falls out. No not at all.
(11)
•••
Boilerroomben
X
Post by
Boilerroomben
on Jan 21, 2023 12:18am
well well well what have we here!
What a great little flip
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers